CYP19A1 and Abdominal obesity: Furthermore, men with congenital oestrogen deficiency due to mutations in the aromatase gene or oestrogen resistance due to oestrogen receptor loss-of-function mutations develop central obesity and hyperinsulinaemia, which, in the case of aromatase deficiency, are corrected by oestrogen replacement (57, 58, 59).